These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
178 related items for PubMed ID: 21565283
1. Clinical features, treatment, and survival of patients with colorectal cancer with or without inflammatory bowel disease. Ali RA, Dooley C, Comber H, Newell J, Egan LJ. Clin Gastroenterol Hepatol; 2011 Jul; 9(7):584-9.e1-2. PubMed ID: 21565283 [Abstract] [Full Text] [Related]
3. Relationship between clinical parameters and the colitis-colorectal cancer interval in a cohort of patients with colorectal cancer in inflammatory bowel disease. Brackmann S, Andersen SN, Aamodt G, Langmark F, Clausen OP, Aadland E, Fausa O, Rydning A, Vatn MH. Scand J Gastroenterol; 2009 Mar; 44(1):46-55. PubMed ID: 18609187 [Abstract] [Full Text] [Related]
4. Colorectal cancer in patients with inflammatory bowel disease after liver transplantation for primary sclerosing cholangitis. Vera A, Gunson BK, Ussatoff V, Nightingale P, Candinas D, Radley S, Mayer A, Buckels JA, McMaster P, Neuberger J, Mirza DF. Transplantation; 2003 Jun 27; 75(12):1983-8. PubMed ID: 12829898 [Abstract] [Full Text] [Related]
5. Risk factors of colorectal cancer in inflammatory bowel disease. Bansal P, Sonnenberg A. Am J Gastroenterol; 1996 Jan 27; 91(1):44-8. PubMed ID: 8561142 [Abstract] [Full Text] [Related]
6. Inflammatory bowel disease confers a lower risk of colorectal cancer to females than to males. Söderlund S, Granath F, Broström O, Karlén P, Löfberg R, Ekbom A, Askling J. Gastroenterology; 2010 May 27; 138(5):1697-703. PubMed ID: 20167217 [Abstract] [Full Text] [Related]
7. Colorectal cancer complicating inflammatory bowel disease: similarities and differences between Crohn's and ulcerative colitis based on three decades of experience. Kiran RP, Khoury W, Church JM, Lavery IC, Fazio VW, Remzi FH. Ann Surg; 2010 Aug 27; 252(2):330-5. PubMed ID: 20622662 [Abstract] [Full Text] [Related]
8. 5-aminosalicylate is not chemoprophylactic for colorectal cancer in IBD: a population based study. Bernstein CN, Nugent Z, Blanchard JF. Am J Gastroenterol; 2011 Apr 27; 106(4):731-6. PubMed ID: 21407180 [Abstract] [Full Text] [Related]
9. Clinical and pathologic outcomes of colorectal cancer in a multi-ethnic population. Koo JH, Kin S, Wong C, Jalaludin B, Kneebone A, Connor SJ, Leong RW. Clin Gastroenterol Hepatol; 2008 Sep 27; 6(9):1016-21. PubMed ID: 18558515 [Abstract] [Full Text] [Related]
10. A matched case-control study of IBD-associated colorectal cancer: IBD portends worse outcome. Hrabe JE, Byrn JC, Button AM, Zamba GK, Kapadia MR, Mezhir JJ. J Surg Oncol; 2014 Feb 27; 109(2):117-21. PubMed ID: 24132737 [Abstract] [Full Text] [Related]
11. Outcomes from IBD-associated and non-IBD-associated colorectal cancer: a Surveillance Epidemiology and End Results Medicare study. Gearhart SL, Nathan H, Pawlik TM, Wick E, Efron J, Shore AD. Dis Colon Rectum; 2012 Mar 27; 55(3):270-7. PubMed ID: 22469793 [Abstract] [Full Text] [Related]
12. Improved survival in young women with colorectal cancer. Koo JH, Jalaludin B, Wong SK, Kneebone A, Connor SJ, Leong RW. Am J Gastroenterol; 2008 Jun 27; 103(6):1488-95. PubMed ID: 18510616 [Abstract] [Full Text] [Related]
13. Does the use of 5-aminosalicylates in inflammatory bowel disease prevent the development of colorectal cancer? Bernstein CN, Blanchard JF, Metge C, Yogendran M. Am J Gastroenterol; 2003 Dec 27; 98(12):2784-8. PubMed ID: 14687833 [Abstract] [Full Text] [Related]
14. Survival after colorectal cancer in patients with Crohn's disease: A nationwide population-based Danish follow-up study. Larsen M, Mose H, Gislum M, Skriver MV, Jepsen P, Nørgård B, Sørensen HT. Am J Gastroenterol; 2007 Jan 27; 102(1):163-7. PubMed ID: 17037994 [Abstract] [Full Text] [Related]
15. Chemoprevention for colon cancer: new opportunities, fact or fiction? Terhaar Sive Droste JS, Tuynman JB, Van Dullemen HM, Mulder CJ. Scand J Gastroenterol Suppl; 2006 Jan 27; (243):158-64. PubMed ID: 16782636 [Abstract] [Full Text] [Related]
16. Rate of early/missed colorectal cancers after colonoscopy in older patients with or without inflammatory bowel disease in the United States. Wang YR, Cangemi JR, Loftus EV, Picco MF. Am J Gastroenterol; 2013 Mar 27; 108(3):444-9. PubMed ID: 23295277 [Abstract] [Full Text] [Related]
17. High lifetime risk of cancer in primary sclerosing cholangitis. Claessen MM, Vleggaar FP, Tytgat KM, Siersema PD, van Buuren HR. J Hepatol; 2009 Jan 27; 50(1):158-64. PubMed ID: 19012991 [Abstract] [Full Text] [Related]
18. [Risk factors for ulcerative colitis associated colorectal cancers in a Hungarian cohort of ulcerative colitis patients]. Lakatos L, Mester G, Erdélyi Z, David G, Pandúr T, Balogh M, Fischer S, Vargha P, Lakatos PL. Orv Hetil; 2006 Jan 29; 147(4):175-81. PubMed ID: 16515026 [Abstract] [Full Text] [Related]
19. Specific clinical and biological features characterize inflammatory bowel disease associated colorectal cancers showing microsatellite instability. Svrcek M, El-Bchiri J, Chalastanis A, Capel E, Dumont S, Buhard O, Oliveira C, Seruca R, Bossard C, Mosnier JF, Berger F, Leteurtre E, Lavergne-Slove A, Chenard MP, Hamelin R, Cosnes J, Beaugerie L, Tiret E, Duval A, Fléjou JF. J Clin Oncol; 2007 Sep 20; 25(27):4231-8. PubMed ID: 17878476 [Abstract] [Full Text] [Related]
20. A meta-analysis of the clinicopathological characteristics and survival outcomes of inflammatory bowel disease associated colorectal cancer. Reynolds IS, O'Toole A, Deasy J, McNamara DA, Burke JP. Int J Colorectal Dis; 2017 Apr 20; 32(4):443-451. PubMed ID: 28078433 [Abstract] [Full Text] [Related] Page: [Next] [New Search]